Drugs repurposing against SARS-CoV2 and the new variant B.1.1.7 (alpha strain) targeting the spike protein: molecular docking and simulation studies

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) is responsible for the global COVID-19 pandemic and millions of deaths worldwide. In December 2020, a new alpha strain of SARS-CoV2 was identified in the United Kingdom. It was referred to as VUI 202012/01 (Alpha strain modelled under inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Pande, Monu, Kundu, Debanjan, Srivastava, Ragini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367657/
https://www.ncbi.nlm.nih.gov/pubmed/34423145
http://dx.doi.org/10.1016/j.heliyon.2021.e07803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367657/
https://www.ncbi.nlm.nih.gov/pubmed/34423145
http://dx.doi.org/10.1016/j.heliyon.2021.e07803

Ejemplares similares